Introduction
Salmonella genomic island 1 (SGI1) is a 42.4-kb integrative mobilizing element first discovered in multidrug-resistant (MDR) Salmonella Typhimurium DT104. Integration of SGI1 into the bacterial chromosome occurs between the chromosomal trmE gene (formerly known as thdF) (for the left junction) and hipB gene (for the right junction) by sitespecific recombination [1] . The SGI1 consists of 28 open reading frames (ORFs; S01-S027 and S044) and MDR region. In the MDR region, antimicrobial resistance genes that confer resistance to ampicillin (bla
), chloramphenicol and florfenicol (floR), streptomycin and spectinomycin (aadA2), sulfonamides (sul1), and tetracyclines (tetA) (ACSSuT phenotype) are clustered together [1] . The MDR region is usually located between the res gene (ORF S027) and ORF S044 at the right end of SGI1 and contains a complex class 1 integron belonging to the In4 type (named In104) [2] . The complex In104 integron variants are bound at the SGI1 backbone by 25-bp inverted repeats (IRi and IRt) and usually carry various antimicrobial resistance gene cassette arrays [1] .
Since the identification of SGI1 in Salmonella Typhimurium DT104, 30 different types or more of MDR regions in SGI1 have been described in many Salmonella species [3, 4] . In addition, genetic variations in SGI1 backbones have been reported, such as single nucleotide polymorphism, insertion sequence-mediated insertion or deletion, and transpositional insertion of a complex class 1 integron at another position [3, 4] . According to differences of antibiotic resistance gene clusters located at MDR regions, SGI1 variants are classified from SGI1-A to SGI1-V, and six SGI variants (SGI1-B, SGI1-K, SGI1-P, SGI1-Q, SGI1-L, and SGI1-J) of them are subdivided into two subgroups or more [5] [6] [7] .
By conjugative helper plasmids of the IncA/C family, SGI1 can be mobilized and transferred among bacteria isolates that belong to Enterobacteriaceae, such as Proteus mirabilis strains [8] . P. mirabilis is a commensal enteric bacterial species present in the intestinal tract of humans and animals, soil, or water. In humans, P. mirabilis is known as an opportunistic pathogen responsible for various infections, such as urinary tract infections. P. mirabilis isolates involved in community-and hospital-acquired infections can harbor diverse antimicrobial resistance mechanisms. The infection rate by MDR P. mirabilis isolates has increased globally in the past few years [9] . Since identification of P. mirabilis clinical isolates harboring SGI1 in 2007, SGI1 variants have been exceptionally detected in many P. mirabilis isolates from humans, companion and food-producing animals, and foodstuffs [10] [11] [12] [13] . Some of the SGI variants are similar to those identified in Salmonella species, but SGI1-PmABB, SGI1-PmGUE, SGI1-PmVER, SGI1-O, SGI1-U, and SGI1-V have mainly been detected in P. mirabilis.
Recently, P. mirabilis strains carrying SGI1-V harboring the extended-spectrum β-lactamase gene (bla
) and acquired quinolone resistance gene (qnrA1) were isolated from humans and animals in France [12, 14] . In addition, P. mirabilis strains harboring diverse SGI1 variants have been isolated from foodstuffs as well as clinical specimens in China and France [14] . The reports underline the importance of SGI1 in contributing to antimicrobial resistance spread among P. mirabilis isolates. Although P. mirabilis strains carrying SGI1 variants have been isolated from humans and animals in Africa, China, France, and Palestine, there is a relative paucity of data on SGI1 in P. mirabilis strains isolated from Korea [13, 15, 16] . The aims of our study were to investigate the prevalence of SGI1 and characterize SGI1 in P. mirabilis isolates from humans and chickens, which is one of the typical food animals in Korea, and to characterize molecularly the collected isolates. In addition, the relationship between gene cassette arrays of MDR regions and antimicrobial resistance was analyzed. In the present study, we report the emergence of P. mirabilis carrying SGI1-PmABB in Korea for the first time.
Materials and Methods

Bacterial Isolates
Twenty P. mirabilis clinical isolates were collected from a university hospital laboratory at Chungcheong Province, Korea between September 2013 and March 2014 from different 20 hospitalized patients. The isolates were recovered from diverse clinical specimens; urine (n = 17), sputum (n = 1), cervix (n = 1), and pleural fluid (n = 1). For long-term storage, all isolates were grown at 37 o C in brain heart infusion broth (Difco Laboratories, USA). Each long-term culture with 20% glycerol was stored at -70 o C until it was analyzed. In parallel, 24 nonredundant P. mirabilis isolates were recovered from ceca of chickens that were grown in Chungcheong Province during the same period. The chicken ceca were obtained three times from one slaughterhouse located in Chungcheong Province. Species identification of the clinical isolates was performed using the Vitek 2 automated instrument ID system (bioMérieux, France).
Isolates from ceca of chickens were identified by analyses of their 16S rRNA sequences after conventional methods for screening Proteus species from the isolates.
Antimicrobial Susceptibility Test
All P. mirabilis isolates were subjected to a susceptibility test against nine antimicrobial agents on Müller-Hinton agar (Difco Laboratories) with the Kirby-Bauer disk diffusion method. The following antimicrobial disks (BBL, USA) were used: amikacin (30 µg), cefotaxime (30 µg), ciprofloxacin (5 µg), gentamicin (10 µg), levofloxacin (5 µg), spectinomycin (100 µg), streptomycin (10 µg), tobramycin (10 µg), and trimethoprim (5 µg). According to the CLSI M100-S21 guidelines, inhibition zones of eight of the antimicrobial disks, except the spectinomycin disk, were measured and evaluated as resistant, intermediate, or susceptible [17] . E. coli strain ATCC 25922 was used as a reference strain. Interpretation of the inhibition zone of the spectinomycin disk was based on the manufacturer's instructions for Neisseria gonorrhoeae.
DNA Extraction and PCR Amplification
Genomic DNA was obtained from each P. mirabilis strain by using a bacteria genomic DNA extraction kit (Bioneer, Korea) according to the manufacturer's instructions. PCR was carried out with the AccuPower PCR PreMix (Bioneer, Korea), containing 20 pmol of each primer, 50 ng of genomic DNA, and sterile water. Each target gene was amplified in a GenePro Thermal Cycler B48D (Bioer Technology Corp. Ltd, China). The thermal cycling conditions consisted of an initial denaturation step at 95°C for 5 min, amplification step of 30 cycles at 95°C for 30 sec, 52°C for 40 sec, and 72°C for 30 sec, and a final extension step at 72°C for 5 min. The annealing temperature was 52°C, unless otherwise specified. The PCR products were separated by electrophoresis on 1.0% agarose gels containing ethidium bromide, and analyzed using a Slite 140 Image System (Novusci, UK). Positive PCR products were purified with a PCR purification kit (Bioneer,
SGI1 Detection and PCR Mapping
The genes associated with SGI1 were detected by PCR using the published primers composed of the int gene of SGI1 and chromosomal thdF gene of P. mirabilis (for the left junction, number 1 primer sets), and of the ORF S044 of SGI1 and chromosomal hipB gene of P. mirabilis (for the right junction, number 2 primer sets). ORF S026 and S044 that contained SGI1 were also detected using number 3 and 4 primer sets, respectively (Table 1) . For the strains harboring the two ORFs and left and right junction regions associated with SGI1, the entire SGI1 backbone was investigated using PCR mapping experiments as described previously [12, 13, 16] . The amplification regions targeted by each primer set are represented in Fig. 1 . To find the MDR region within the SGI1 backbone, primers were chosen in ORF S026 of SGI1 and the first gene of the MDR region (for the left junction, number 22 primer sets) and in ORF S044 of SGI1 and the last gene of the MDR region (for the right junction, number 24 primer sets). Subsequently, the MDR region was identified by PCR mapping using primers chosen in the 5' and 3' conserved segments located in class 1 integron. Each PCR product was purified and sequenced with a BigDye Terminator Cycle Sequencing Kit (PE Applied Biosystems, USA) and an ABI PRISM 3730XL DNA analyzer (PE Applied Biosystems). DNA fragments (1 kb or more in size) were sequenced by using the overlapping PCR method. Each DNA sequence was confirmed by using the BLAST paired alignment facility (http:// blast.ncbi.nlm.gov). Molecular Typing by REP-PCR Molecular typing of the P. mirabilis isolates was performed using REP-PCR with primers REP1 (5'-IIIGCGCCGICATCAGGC-3') and REP2 (5'-ACGTCTTATCAGGCCTAC-3') [18] . After an initial denaturation step at 95°C for 5 min, the PCR mixture was subjected to an amplification step of 35 cycles at 95°C for 1 min, 48°C for 1 min, and 70°C for 6 min, followed by a final extension step at 70°C for 10 min. The amplified products were subjected to electrophoresis on 1.5% agarose gels containing 0.5 mg/l ethidium bromide and visualized with a Slite 140 Image System (Novusci, UK). Isolates belonging to the same clonal clusters displayed identical REP-PCR profiles with the same band sizes and densities.
Results
Antimicrobial Susceptibility of P. mirabilis Isolates Containing SGI1
Four of 44 P. mirabilis isolates involved in this study contained left and right junctions and two ORFs (S026 and S044) of SGI1, and they were all isolated from ceca of chickens. We compared the antimicrobial resistance rates of isolates harboring SGI1 to those of isolates not harboring SGI1 to investigate any correlation between containing SGI1 and showing antimicrobial resistance in P. mirabilis isolates ( Table 2 ). Isolates not containing SGI1 identified in this study showed high-level resistance to streptomycin (82.5%) and spectinomycin (80.0%), but lower resistance in response to gentamicin (42.5%) and trimethoprim (57.5%) than the two antimicrobial agents. However, all of the isolates containing SGI1 showed resistance to gentamicin, streptomycin, spectinomycin, and trimethoprim.
Characterization of SGI1
Among the 44 P. mirabilis isolates tested, four (9.1%) isolated from chicken ceca carried SGI1, but SGI1 was not found in P. mirabilis strains isolated from humans. To investigate the types of SGI1 backbones, the regions spanning from the chromosomal gene thdF to hipB/hipA were amplified using 15 specific primer sets, followed by PCR mapping. Through PCR mapping, the SGI1 backbones (33.0 kb) detected in the four P. mirabilis isolates from chicken ceca were all confirmed as SGI1-PmABB. The structures of the SGI1 backbone and SGI1-PmABB are presented in Fig. 2 . SGI1-PmABB harbored a 2,780 bp deletion region spanning from ORF S005 to S009 that Table 2 . Antimicrobial susceptibilities of P. mirabilis strains isolated from clinical specimens and chicken ceca to nine antimicrobial agents. belonged to 28 ORFs of SGI1 backbone. The deletion region was replaced by the insertion sequence element IS1359 (ISVch4). Subsequently, it was confirmed by PCR mapping that the MDR region was located between the res gene and OFR S044 of SGI1-PmABB. The MDR region included a class 1 integron containing aacCA5 and aadA7 gene cassettes and belonging to the In4 family (Fig. 2 ).
Molecular Typing
All P. mirabilis isolates were typed by REP-PCR. Although most P. mirabilis isolates from humans showed diverse patterns, P. mirabilis isolates from chicken ceca displayed the same REP-PCR type in a few strains (Fig. 3) . In particular, the four P. mirabilis isolates containing SGI1-PmABB all displayed the identical REP-PCR type.
Nucleotide Sequence Accession Numbers
The SGI1-PmABB sequence of P. mirabilis strains from chicken ceca has been deposited in GenBank under the accession number JX121638.
Discussion
For detection of P. mirabilis strains carrying SGI1, a total of 44 isolates were collected from nonredundant clinical specimens and chicken ceca. The four P. mirabilis strains (16.7%) from chicken harbored a SGI1, whereas none of the isolates from the clinical specimens contained SGI1. Surprisingly, the isolation rate (16.7%) of SGI1-bearing P. mirabilis strains confirmed in our study was much higher than that of SGI1-bearing P. mirabilis strains from chicken (9.4%) or swine (4.9%) in China [16, 19] . In contrast, our isolation rate from chicken was similar to that (15.6%) of SGI1-bearing P. mirabilis strains from dogs in France, where P. mirabilis isolates carrying SGI1 was first reported and more research of SGI1 continued [14] . The report suggested a wide dissemination of SGI1-bearing P. mirabilis isolates in humans and dogs. A risk of potential transmission of the SGI1-bearing isolates may occur between dogs and their owners because there is usually close contact between them. Therefore, further investigations about SGI1 in P. mirabilis isolates from dogs or other companion animals are necessary. SGI1s were detected in 9.6% of P. mirabilis isolates from clinical specimens in France, but not detected in the isolates from clinical specimens involved in our study. The prevalence of P. mirabilis strains containing SGI1 from humans or animal specimens has not been assessed before in Korea. In the present study, we investigated P. mirabilis carrying SGI1 for the first time in Korea.
Through PCR mapping, the four SGI1 backbones detected in our study were all confirmed as the SGI1-PmABB previously reported in China, France, and Africa [13, 15, 16] . The SGI1 variants have different structures of MDR regions and/or backbones from one another. The SGI1-PmABB detected in this study contains a deletion region from ORF S005 to S009 replaced by the insertion of IS1359 and a simple MDR region composed of a single integron [13] . The class 1 integron contained in SGI1-PmABB harbored antimicrobial resistance genes that confer resistance to gentamicin, sisomicin, and fortimicin (aacCA5) and streptomycin and spectinomycin (aadA7). Subsequently, we compared the resistance rates of gentamicin, streptomycin, and spectinomycin between SGI1-bearing isolates and SGI1-not bearing isolates (Table 2) . Isolates containing SGI1 all showed resistance to the three antimicrobial agents, whereas isolates not containing SGI1 showed diverse resistance rates to gentamicin (42.5%), streptomycin (82.5%), and spectinomycin (80.0%). These results emphasized the importance of SGI1 playing a role of horizontal gene transfer platforms.
Through results of clonal characteristic analysis by REP-PCR, we confirmed no clonal relationship among the P. mirabilis isolates from clinical specimens. However, the four P. mirabilis strains containing SGI1-PmABB and isolated from chicken ceca showed the same REP-PCR pattern. This pattern occurrence suggests that there were both horizontal and clonal spread of SGI1-bearing P. mirabilis isolates in the poultry farm in Chungcheong, Korea. The prevalence of SGI1-bearing P. mirabilis isolates in poultry farms may pose a threat to public health, as the isolates can spread to humans through food consumption. In addition, transfer of SGI1s into diverse enterobacterial species harboring a conjugative A/C plasmid was demonstrated recently. The mobilization ability of SGI1s might lead to them spreading among clinical isolates belonging to Enterobacteriaceae [20] . Fortunately, P. mirabilis strains containing SGI1-PmABB were not detected from clinical specimens in our study but have been isolated from humans in France and Africa [13, 15] . P. mirabilis is an enteric bacterial species that should be considered a potential reservoir of SGI1s. Recently, novel SGI1 variants containing diverse antimicrobial resistance genes have been reported, and P. mirabilis strains carrying the SGI1 variants play a role as an opportunistic MDR pathogen to humans and animals [21] . In the present study, we reported first the isolation of P. mirabilis strains containing SGI1-PmABB in Chungcheong Province, Korea. To the best of our knowledge, SGI1-bearing P. mirabilis isolates have not been confirmed in Korea previously. Accordingly, the present study emphasizes the need for continuous monitoring of SGI1s to successfully stop the spread of the MDR genomic islands among P. mirabilis isolates from humans and animals.
